NEUTRALIZING GP41 ANTIBODIES AND THEIR USE
US Application 61/672,708
Filed on 2012-07-17
Filed on 2012-07-17
HIV-Neutralizing Polypeptides And Methods Of Their Use.
US Application 61/649,150
Filed on 2012-05-18
Filed on 2012-05-18
Novel Attenuated Vaccine
US Application 61/753,320
Filed on 2013-01-16
Filed on 2013-01-16
A Formulation Of Mycobacterial Components As An Adjuvant For Inducing Th17 Response
US Application 61/709,713
Filed on 2012-10-04
Filed on 2012-10-04
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing
US Application 61/484,184
Filed on 2011-05-09
Filed on 2011-05-09
HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES
US Application 61/559,359
Filed on 2011-11-14
Filed on 2011-11-14
HIV NEUTRALIZING PEPTIDES AND METHODS OF THEIR USE
US Application 61/736,350
Filed on 2012-12-12
Filed on 2012-12-12
BISPECIFIC ANTIBODIES TO TREAT HIV-1 INFECTION
US Application 61/638,437
Filed on 2012-04-25
Filed on 2012-04-25
Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines
US Application 61/554,136
Filed on 2011-11-01
Filed on 2011-11-01
ASSAY FOR DIABETES-ASSOCIATED AUTOANTIBODIES
US Application 61/558,193
Filed on 2011-11-10
Filed on 2011-11-10